Pediatrics

>

Latest News

Pediatric EoE: FDA Accepts dupilumab sBLA for priority review in children younger than 12 years image credit FDA logo© Araki Illustrations/stock.adobe.com
Pediatric EoE: FDA Accepts Dupilumab sBLA for Priority Review in Children Younger than 12 Years

September 29th 2023

Dupilumab, a monoclonal antibody targeting type 2 inflammation, would be the first treatment of its kind for younger children with eosinophilic esophagitis.

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope  ©New Africa/AdobeStock
Daily Dose: Early Childhood Obesity Treatment Found Effective Long-Term

September 25th 2023

Early Initiation of Childhood Obesity Treatment Linked to Better Weight Outcomes Over Time / Image credit: ©Protsenko Dmitriy/AdobeStock
Early Initiation of Childhood Obesity Treatment Linked to Better Weight Outcomes Over Time

September 20th 2023

SSRI Treatment May Decrease Risk for Postnatal Depression-Associated Outcomes for Mother, Child / Image credit: ©grooveriderz/AdobeStock
SSRI Treatment May Decrease Risk for Postnatal Depression-Associated Outcomes for Mother, Child

September 5th 2023

Consider Age when Assessing Children for COVID-19 Severity, Advise Authors of New Study / Image credit: ©amedeomaja/AdobeStock
Consider Age when Assessing Children for COVID-19 Severity, Advise Authors of New Study

August 24th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.